Penumbra Inc (NYSE:PEN)
| 269.67 Delayed Data As of Mar 21 |  -0.40 / -0.15%Today’s Change | 114.87 Today|||52-Week Range 274.71 | +21.22% Year-to-Date |
Latest PEN News | Press Releases
| Should iShares Morningstar Small-Cap Growth ETF (ISCG) Be on Your Investing Radar? Mar 13 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 270.07 |
| Today’s open | 267.99 |
| Day’s range | 265.09 - 270.63 |
| Volume | 281,210 |
| Average volume (3 months) | 339,246 |
| Market cap | $10.0B |
Data as of 3:59pm ET, 03/21/2023
Growth & Valuation
| Earnings growth (last year) | -136.81% |
| Earnings growth (this year) | +662.16% |
| Earnings growth (next 5 years) | +91.73% |
| Revenue growth (last year) | +13.32% |
| P/E ratio | NM |
| Price/Sales | 9.94 |
| Price/Book | 10.08 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TFXTeleflex Inc | -0.04 | -0.02% |
| SWAVShockwave Medical In... | +8.31 | +4.02% |
| ---- | ||
| IARTIntegra Lifesciences... | +0.75 | +1.39% |
Data as of 4:00pm ET, 03/21/2023
Financials
| Next reporting date | May 9, 2023 |
| EPS forecast (this quarter) | $0.11 |
| Annual revenue (last year) | $847.1M |
| Annual profit (last year) | -$2.0M |
| Net profit margin | -0.24% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Alameda, California |
Forecasts
